11 results · 29ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ellacor System with Micro-Coring Technology

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

Darby Dental Supply, LLC

FDA UDI
DARBY DENTAL SUPPLY, LLC·00889813053669·BITE REG FS 50ML WINTERMINT

APEX Revision Knee

FDA UDI
Omni Life Science, Inc.·00841690124610·Modular Offset Stem 17mm x 150mm x 2mm

Med-link Pulse Oximeter

FDA 510(k)
FDA Class 2 ·Cardiovascular

AXS Vecta 46 Intermediate Catheter

FDA 510(k)
FDA Class 2 ·Cardiovascular

NATURALYTE

FDA Adverse Event
Death ·FRESENIUS MEDICAL CARE NORTH AMERICA·Product code KPO·November 13, 2014

SMOOTH HIGH PROFILE GEL MAMMARY PROSTHESES

FDA Adverse Event
Injury ·MENTOR WORLDWIDE LLC·Product code FTR·September 15, 2011

9900

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·July 25, 2013

COMPUTER SYSTEM EPICENTER FOR BDNLA

FDA Adverse Event
Injury ·BECTON DICKINSON DE MEXICO·Product code JQP·August 24, 2021

MENTOR SILTEX ROUND MODERATE PROFILE

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code FWM·August 16, 2018

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014